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A B S T R AC T
Hepatitis B virus (HBV) remains a leading cause of chronic hepatitis, maternal complications, and neonatal deaths in sub-
Saharan Africa. Pregnant women serve as a major reservoir for the persistence and ongoing transmission of hepatitis B virus and 
HIV in a generalized heterosexual epidemic. The aim of this study is to assess the epidemiology of Hepatitis B infection among 
pregnant women in South West-Nigeria. This is a cross-sectional study of 353 pregnant women across 10 health facilities in the 
region. Results showed that of the 353 pregnant women tested, 37 were positive for the HBV antigen giving a prevalence estimate 
of 10.5% (95% CI: 7.5%–14.2%). We found significant negative association between odds of HBV infection and knowledge of 
HBV transmission through sex (OR: 0.30: 95%CI–0.11–0.82) and a positive association with blood transfusion in the past three 
months (OR: 9.5: 95% CI-1.58–57.14). Findings strongly suggest high endemicity of HBV and the possible implication of blood 
transfusion as a major route of ongoing HBV transmission among pregnant women in south-western Nigeria. We recommend 
further study of a prospective design to investigate the possible causal link between blood transfusion and the risk of HBV 
infection among pregnant women in Nigeria.
© 2018 Atlantis Press International B.V. 
This is an open access article under the CC BY-NC license (http://creativecommons.org/licences/by-nc/4.0/).
* Corresponding author. Email: glory.atilola@northumbria.ac.uk
1. INTRODUCTION
The significance of hepatitis B virus (HBV) infection as a public 
health issue is of topmost concern in sub-Saharan Africa, partic-
ularly in Nigeria [1]. According to the most recent report by the 
World Health Organization (2016), the current global burden of 
hepatitis B infection is estimated to be 2 billion, of which 360 mil-
lion are chronically infected at the end of 2016, while 620,000 deaths 
occur annually [2]. Despite the fact that Hepatitis B virus accounts 
for more deaths than each of HIV, tuberculosis and malaria [2], the 
performance metrics of awareness, knowledge of transmission, vac-
cine prevention and control remain low in most affected (high risk) 
populations such as pregnant women in developing countries [3].
In sub-Saharan Africa, hepatitis B virus remains a leading cause 
of chronic hepatitis, maternal complications, and neonatal deaths. 
Pregnant women therefore, serve as a major reservoir for the per-
sistence and ongoing transmission of the virus within popula-
tions [4,5]. HBV burden is further worsened by the high risk of 
co-infection with HIV within a generalized epidemic and poverty 
in this part of the world [1,2]. Hepatitis B virus remains the most 
significant viral hepatitis due to the high transmission potential 
through blood and body fluids, especially among pregnant women 
[5,6]. Its ability to cause chronic liver diseases such as liver cirrhosis 
and hepatocellular carcinoma, and a number of obstetric compli-
cations, before, during and after birth cannot be overlooked [6]. 
Similarly, pregnancy triggers physiological and in immunological 
response and a well known effect is the shift in the T helper 1-T 
helper 2 balance towards a T helper 2 response, which increases the 
presence/secretion of regulatory T cells and in turn contributes to 
a depressed immune response against the HBV pathogen [6]. This 
key change lowers the body’s ability to mount an effective immune 
response, thereby resulting in the successful infection and prolif-
eration of HBV DNA [6]. Such pregnant women are therefore at 
heightened risk of onward transmission to the unborn child espe-
cially in the absence of vaccine or prophylactic measures during the 
early phase of antenatal care.
The emergence of HIV in the past four decades, further worsened 
the complications due to hepatitis B infection in pregnant women 
as well as in the general population [7,8]. Furthermore, the highly 
contagious nature of both viral infections and common route of 
transmission through blood and body fluids especially during 
unprotected heterosexual contact, mother to child transmission, 
and ability to cause chronic disease state in affected individuals, 
account for the dual burden of co-morbidity due to hepatitis B and 
HIV in pregnant women [8]. This has a broader implication in a 
generalized HIV epidemic context. Maternal complications due to 
HBV and HIV co-infection pose significant threat to the survival of 
both the mother and unborn child. On the other hand, in a low-re-
sourced country such as Nigeria, the economic cost attributable to 
the impact of HIV and HBV coinfection has been well documented 
both at the microeconomic (individual) and the macroeconomic 
(household and population) levels [9]. In addition, a major epide-
miologic implication is the increasing probability of dual transmis-
sion of new HBV/HIV infections in a mixed setting creating new 
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chimeric recombinant forms (hitherto unknown) which may even 
pose a greater threat than the two separate epidemics.
Prevalence estimate of hepatitis B and co-infection with HIV has 
been reported across a number of studies conducted in various 
parts of Nigeria. Studies conducted in northern Nigeria showed 
evidence of intermediate to high hepatitis B burden in the north-
ern region. For instance, Ndams et al. [10] reported a prevalence 
of 12.3% in a cross-sectional study of hepatitis B in 261 pregnant 
women in Minna, with the highest rate observed in the middle age 
group who are more likely to be sexually active than the younger 
or older age groups [10]. Findings from the study was further 
supported by a similar cross-sectional screening of 231 pregnant 
women attending antenatal clinic at the Federal Medical Centre, 
Yola, where an estimated 8.2% of the women had hepatitis B infec-
tion with the highest rate found in women in the middle age group 
[11]. Similarly, a 3.9% rate of HBV/HIV co-infection was found in 
8000 women attending antenatal care across four health facilities in 
Kaduna in an unpublished study by Oneh, 2013 [12]. Furthermore, 
studies conducted in southern Nigeria provide evidence of a mod-
erate to high prevalence burden of hepatitis B and co-infection 
with HIV in the region. A case in point is a study by Ojide and 
colleagues with a reported estimate of 15.5% prevalence rate of 
hepatitis B surface antigen in HIV outpatients clinic in Benin City, 
Nigeria [13]. In a separate study conducted by Oladeinde et al., 
2013 [14] in the same region, prevalence of HBV and HIV infec-
tions was found to be 2.2% and 7.2% respectively. This study found 
the highest rate of infections in pregnant women with no formal 
education and with multiple sexual partners, which provides sup-
port for the role of mother’s education as an effective preventive 
intervention as well as the well known impact of multiple hetero-
sexual partnerships in the occurrence of new infections especially 
in the general population.
However, prevalence situation in the Niger Delta reveals a low to 
moderate burden. A 3% point prevalence was observed in a cohort 
of 10,032 pregnant women attending antenatal at the Braithwaite 
Memorial hospital in Port Harcourt [15]. Buseri et al. (2010) [16] 
also reported a 5.3% and 4.1% prevalence of HBV and HIV infec-
tions respectively in 1000 apparently healthy pregnant women in 
the reproductive age group in the same region.
Furthermore, blood transfusion has been implicated as a major 
route of HBV and HIV transmission in the pregnant women popu-
lation after heterosexual contact, particularly in sub-Saharan Africa 
[17,18]. It was also observed that significant differential exist with 
regard to hepatitis B and HIV infections between pregnant women 
receiving blood transfusion and those who do not as reported by 
studies in both developing and developed countries [19,20]. In 
the same vein, despite high efficacy of HBV vaccine, low vaccine 
awareness, availability and affordability and immunization-related 
challenges affect uptake among pregnant women in Nigeria and 
thus account for the upward trend observed in recent years across 
the country [21,22].
Sadly, the government of Nigeria, till date, has no formal guidelines 
for the treatment and prevention of viral hepatitis in the general 
population and in pregnant women. As a result, there are no readily 
available services for pregnant women in most parts of the country 
and where services are available, the cost of screening and vaccine 
uptake continue to put these services out of the reach of the bottom 
majority who need it most.
However, few studies so far, have assessed the burden of hepatitis 
B and HIV co-infection and risk factor profile in pregnant women 
in Nigeria. The most recent attempt to estimate the burden of HBV 
in the region was a study by Anaedobe et al. (2015) which only 
considered 180 pregnant women all screened from the University 
College Hospital Ibadan, a tertiary hospital in the region [23]. In 
this study, we attempt to provide an improved and more represen-
tative estimate of the HBV prevalence burden in the region. Also, 
most of the reviewed studies from the extant body of literature are 
descriptive at best with little effort made to identify specific risk 
factors of infections in this high risk population. This study is 
therefore an attempt to fill the gap in knowledge, risk factors and 
population impact of hepatitis B infection in pregnant women and 
make useful recommendations informed by study findings.
2. METHODOLOGY
In this section, we describe the design process, field implemen-
tation and analytical procedures that were carried out in order to 
achieve the set objectives of this study.
2.1. Study Design
This study is a cross-sectional design set up to examine randomly 
selected samples of pregnant women attending antenatal care in ten 
(10) maternity centers in south-west Nigeria. A structured ques-
tionnaire with closed ended questions about HIV/HBV history and 
exposure of study participants was employed to collect data on each 
consenting individual.
2.2. Study Settings and Population
This study was conducted across 10 maternity facilities of the 
Redeemed Christian Church of God in Ogun and Lagos States. 
These maternities are set up to provide maternal and child health 
services (including HIV treatment and prevention) to pregnant 
women and nursing mothers within the community where they 
are resident. Overall, it renders services to a population of approx-
imately 280,000 pregnant women nationwide. Pregnant women 
were randomly selected from the locations presented in Table 1 
Table 1 | Distribution of study centre across ten facilities in Lagos and 
Ogun states and the geographic coordinates
Location of 
maternity centre State
Local 
government  
area
Npop
Geographic 
coordinates of 
LGA
Mowe Ogun Obafemi Owode 800 6.80596, 3.43803
Ibafo Ogun Obafemi Owode 700 6.74015, 3.42208
AkuteAjunwo Ogun Ifo NA 6.67777, 3.35871
Agbado crossing Lagos Agbado 280 6.71380, 3.28515
Redemption Camp Ogun Obafemi Owode 4500 6.4531, 3.3958
Sabo Ikorodu Lagos Ikorodu West 3000 6.61941, 3.51045
Ipaja Lagos Alimosho 120 6.60541, 3.27989
AgbadoKollinton Lagos Ifako-Ijaye 1200 6.71380, 3.28515
Shagamu Ogun Sagamu 200 6.77880, 3.62178
Abuleiroko Ogun Ado-Odo/Ota 170 6.69916, 3.26385
Npop, Annual average population size attending antennal care at maternity.
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along with the average population size of pregnant women attended 
to in each maternity centre in a year.
2.3. Inclusion and Exclusion Criteria
All consenting pregnant women between age 15 and 49 years were 
considered eligible to participate in this research. Medical as well as 
religious birth attendants in the selected study sites were excluded 
from the study.
2.4. Study Sample and Sampling Method
In order to obtain the required sample size for this study, the 
formula:
 Sample size Z p p d= −
−1 2
2 21a / ( ) /  (1)
was considered [24]. In the above formula, Z1-α/2 is the standard 
normal variate with the value of 1.96 to estimate the significance 
of the P values at 5% type 1 error (P < 0.05), p is the expected pro-
portion of P is the expected proportion of pregnant women with 
Hepatitis B infection in South West Nigeria – 0.08 as reported 
in a previous study in the same region [23]. Finally, the absolute 
error or precision d of 0.04 was chosen for this study. From the 
above formula in equation (1), we obtained a direct sample size 
estimate of 177. However, as a final adjustment to the sample size, 
we accounted for a 20% non response rate and a resulting final 
sample size of 350. A total of 353 consenting pregnant women 
were included in this survey. A simple random sampling approach 
was used at each Maternity Centre to recruit the number required 
for each stratum (i.e. pregnant women) Whenever a pregnant 
woman refused to participate, a suitable replacement was con-
sidered until the required sample size was attained. A sampling 
frame that contained a list of all pregnant women attending 
maternity was generated from the 10 study sites. Each Maternity 
Centre keeps record of the medical history of all pregnant women 
attending antenatal care.
2.5. Data Collection
Data was collected on demographic variables such as age, educa-
tion, and marital status. Knowledge and risk assessment variables 
such as HIV routes of transmission, and prevention methods, age 
at first sex, casual and regular sexual partner in the past 3 months, 
multiple sexual partners and history of sexually transmitted infec-
tions in the last three months were also generated using an anon-
ymous self-administered questionnaire. A total of 12 paid study 
assistants were used for the distribution of the questionnaires to 
selected pregnant women who also retrieved the questionnaires. 
The technical assistance of the Redeemed Action Programme 
Action Committee on AIDS (RAPAC) was solicited in the conduct, 
administration and testing of study participants across the various 
study locations. To ensure that study participants have full com-
prehension of questions, participants had interviewed in their first 
language of choice.
This study examined the knowledge level of pregnant women about 
hepatitis B virus infection (HBV) such as; person to person spread 
of HBV, previous HBV testing, knowledge of result, ever gone for 
treatment, HBV as a cause of liver cancer, prevention of HBV infec-
tion by use of vaccine, and sexual and blood transmission of the 
virus. Complaints of genital sores or ulcers were also noted. All 
variables were close-ended with a binary code assigned “yes = 1” 
and “no = 0”.
2.6. Data Management
Data management activities such as validation of correctness and 
completeness of each questionnaire, data entry and coding for 
analysis were carried out in Excel spreadsheet. The cleaned data 
was exported into Stata version 12.1 statistical software package for 
analysis by a Statistician.
2.7. Data Analysis
Descriptive analysis was carried out according to the objectives of 
this study. Summary statistics such as mean and standard deviation 
were employed to describe continuous variables while frequency 
tables and percentages were utilised for categorical responses. 
Significant difference and association between variables were 
assessed at 95% level of confidence and 5% alpha level. This implies 
that only probability values (p-values) that are <0.05 are considered 
significant. Findings were also presented in tables and graphs.
2.8. Reliability and Validity
The reliability of the self-developed questionnaire was assessed by 
administering it to a small sample of 20 pregnant women twice and 
measuring the reliability ratio. The content validity of the ques-
tionnaire was assessed by an experienced researcher in the field of 
HIV/HBV and pre-tested on a small sample of 20 non- eligible par-
ticipants (i.e. those who were in management positions) selected 
across the maternity centers. The objectives of the exercise were 
explained to them that they were meant to assist in assessing 
the clarity of questions, usability and logistics of administration. 
Subsequently, necessary adjustments were made using this infor-
mation. The participants used for reliability and validity checks 
were excluded from the final research since they had been sensi-
tized to the research questions and some of them did not meet the 
inclusion criteria.
2.9. Bias
This study may be subject to various kinds of bias commonly asso-
ciated with cross-sectional survey research. For instance, selection 
bias may occur due to the fact that pregnant women who attended 
these maternities are more likely to be affiliated to the Redeemed 
Christian Church of God (RCCG) Mission. To minimize non- 
response bias, the questionnaire was made anonymous and con-
fidentiality of test results assured. Voluntary consent form was 
completed and collected before the questionnaires were handed 
to the participants. There was also the possibility of recall bias as 
respondents had to recall past experiences to answer the questions 
in the questionnaire.
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2.10. Ethical Considerations
As part of ethical considerations, participants were made to give 
their fully informed consent by signing the consent form, on 
which was stated the summary of the research project (title, scope, 
aims and purpose), benefits to society and study participants. The 
consent form clearly stated the voluntary nature of the research 
indicating that participants are free to decline to participate. The 
questionnaire did not capture the participants’ identification par-
ticulars, thus ensuring anonymity
3. RESULTS
3.1. Brief Description of Study Facilities
This study was conducted across ten health facilities as presented 
in Table 1 along with their geographic coordinates in two states of 
south-west Nigeria. The annual average of antenatal visits across 
these facilities range from a 120 patients to 4500 patients with an 
overall estimated average of 1219 patients per year. (This excludes 
the Akute Ajuwon centre with no information available). The over-
all response rate for this study was 100%.
4.  BRIEF DESCRIPTION OF STUDY  
PARTICIPANTS
We present the distribution of study participants across the ten 
facilities by socio-demographic characteristics in Table 2. A total 
of 353 pregnant women on antenatal care participated in the study 
with 100% overall response rate to survey structured questionnaire 
and HBV testing. Highest rate of participation (69%) was found 
in pregnant women in the 25–34 years age group comprising of at 
least 60% of respondents across all the health facilities (Table 2). 
A significant number of the respondents (≥84%) were married with 
at least primary education. This trend was consistently observed 
across the ten facilities.
5.  HIV PREVALENCE IN STUDY  
POPULATION
Table 3 shows the distribution of HBV seropositivity status of 
the study population tested across the ten facilities. The over-
all prevalence of HBV infection was estimated at 10.5% (95%CI: 
7.5%–14.2%) derived from a total of 37 positive cases in the study 
population. The highest prevalence rate was observed in the RCCG 
health facility while the lowest rate of 0% was found in Abule Egba 
health facility (Table 3).
6.  HBV PREVALENCE ESTIMATES  
DISTRIBUTION BY SOCIO- 
DEMOGRAPHIC CHARACTERISTICS
Table 4 shows prevalence distribution of HBV by key socio-demo-
graphic characteristics of study participants. Highest prevalence 
of HBV infection was observed in pregnant women in the 25–34 
years age group with an estimate of 12.2% HBV infection in the 
study population. The oldest group (≥35 years) had similar rate 
(6.8%) to pregnant women in the lowest age bracket (5.7%) had 
relatively similar infection rate. In addition, an absolute rate dif-
ference of 7.6% was observed in HBV infection between pregnant 
Table 2 | Distribution of study participants across the ten facilities by socio-demographic characteristics
Variable
Ibafo 
(N = 39) 
n(%)
Shagamu 
(N = 29) 
n(%)
Abule Iroko 
(N = 20) 
n(%)
Agbado crossing 
(N = 20) 
n(%)
Akute Ajuwon 
(N = 40) 
n(%)
Camp 
(N = 51) 
n(%)
Ipaja 
(N = 26) 
n(%)
Kollington 
(N = 45) 
n(%)
Mowe 
(N = 43) 
n(%)
Sabo Ikorodu 
(N = 40) 
n(%)
Total 
(N = 353) 
n(%)
Age
 15–24 1(2.6) 2(6.9) 4(20.0) 1(5) 2(5) 3(5.9) 4(15.4) 2(4.4) 10(23) 6(15) 35(10)
 25–34 29(74.4) 23(79.3) 15(75) 15(75) 31(77.5) 36(70.6) 15(57.7) 31(68.9) 26(61) 24(60) 245(69)
 >=35 9(23.1) 4(13.8) 1(5) 4(20) 7(17.5) 12(23.5) 7(26.9) 12(26.7) 7(16) 10(25) 73(21)
Marital status
 Single 3(7.7) 0(0.0) 2(10) 0(0) 1(2.5) 0(0) 0(0) 2(4.4) 7(16) 2(5) 17(5)
 Married 36(92.3) 29(100) 18(90) 20(100) 39(97.5) 51(100) 26(100) 43(95.6) 36(84) 38(95) 336(95)
State of residence
 Ogun 39(0.0) 29(100) 12(60) 14(70) 40(100) 50(98) 0(0.0) 0(0) 43(100) 0(0) 227(64)
 Lagos 0(0.0) 0(0.0) 8(40) 6(30) 0(0) 1(2) 26(100) 45(100) 0(0) 40(100) 126(36)
Education
 None 1(2.6) 0(0.0) 0(0) 2(10) 2(5.1) 0(0) 1(4) 1(2.2) 0(0) 0(0) 7(2)
 Primary 18(46.2) 12(41.4) 6(30) 3(15) 18(46.2) 36(73.5) 6(24) 22(48.9) 12(29) 12(31) 145(42)
 Second 6(15.4) 2(6.9) 3(15.0) 5(25) 4(10.3) 3(6.1) 8(32) 10(22.2) 3(7) 4(10) 48(14)
 Higher 14(35.9) 15(51.7) 11(55) 10(50) 15(38.5) 10(20.4) 10(40) 12(26.7) 27(64) 23(59) 147(42)
Table 3 | Distribution of Hepatitis B seropositivity across the ten facilities
HBV status Ibafo n (%)
Shagamu 
n (%)
Abule 
n (%)
Agbado 
n (%)
Akute- 
n (%)
Camp 
n (%)
Ipaja 
n (%)
Kollington 
n (%)
Mowe 
n (%)
Ikorodu 
n (%)
Negative 36(92.3) 27(93.1) 20(100) 19(95) 35(87.5) 34(66.7) 25(96.2) 44(97.8) 41(95.4) 35(87.5)
Positive 3(7.7) 2(6.9) 0(0) 1(5) 5(12.5) 17(33.3) 1(3.9) 1(2.2) 2(4.7) 5(12.5)
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Table 4 | Bivariate assessment of Hepatitis B seropositivity by socio-
demographic variables
Variable N HBV positive n (%)
HBV negative 
n (%) p-value
Age 0.261; chi2(2) = 2.69
 15–24 35 2(5.7) 33(94.3)
 25–34 245 30(12.2) 215(87.8)
 ≥ 35 73 5(6.8) 68(93.2)
State of origin 0.024; Chi2(1) = 5.07
 Lagos 126 7(5.6) 119(94.4)
 Ogun 227 30(13.2) 197(86.8)
Parity 0.035; Chi(2) = 9.011; 
Fisher’s exact = 0.024
 0 74 2(2.7) 72(97.3)
 1 135 14(10.4) 121(89.6)
 ≥2 104 15(14.4) 89(85.6)
Education 0.576; Chi2(3) = 1.98
 none 7 0(0.0) 7(2.3)
 primary 145 18(12.4) 127(87.6)
 secondary 48 6(12.5) 42(87.5)
 higher 147 13(8.8) 134(91.2)
Total 353 37(10.5%) 316(89.5%)
Table 5 | Assessment of the differences between Hepatitis B positive and 
negative participant with respect to HBV knowledge and exposure profile
Variable N
HBV 
positive
n (%)
HBV 
negative
n (%)
p-value
Previous HBV test 0.086; chi2(1) = 2.95
 no 260 32(86.5) 228(72.2)
 yes 87 5(13.5) 82(25.9)
 non-response 6 0(0) 6(1.9)
Previous HBV 
result
<0.001; chi2(1) = 
16.95 exact; 0.057
 no 86 4(10.8) 82(25.9)
 yes 1 1(2.7) 0(0.0)
 non-response 266 32(86.5) 234(74.1)
HBV more easily 
spread than HIV
0.012; chi2(1) = 6.27
 no 123 20(54.1) 103(32.6)
 yes 224 17(45.9) 207(65.5)
 non-response 6 0(0) 6(1.9)
Blood transfusion 
in the past  
3 months
0.012; chi2(1) = 6.309 
exact; 0.042
 no 343 34(91.9) 309(97.8)
 yes 8 3(8.1) 5(1.6)
 non-response 2 0(0) 2(0.6)
Think HBV can 
cause liver cancer
0.700; chi2(1) = 0.148
 no 217 22(59.5) 195(61.7)
 yes 131 15(40.5) 116(36.7)
 non-response 5 0(0) 5(1.6)
HBV vaccine can 
prevent infection
0.245; chi2(1) = 1.351
 no 11 0(0.0) 11(3.5)
 yes 337 37(100.0) 300(94.9)
 non-response 5 0(0) 5(1.6)
HBV transmission 
through blood
0.221; chi2(1) = 1.500
 no 26 5(13.5) 21(6.6)
 yes 270 30(81.1) 240(75.9)
 non-response 57 2(5.4) 55(17.4)
HBV transmission 
through sex
0.013; chi2(1) = 6.231 
exact; 0.022
 no 27 7(18.9) 20(6.3)
 yes 281 28(75.7) 253(80.1)
 non-response 45 2(5.4) 43(13.6)
Genital sores 0.414; chi2(1) = 0.667
 no 335 35(94.6) 300(94.9)
 yes 11 2(5.4) 9(2.8)
 non-response 7 0(0) 7(2.2)
HBV risk score 0.154
 Mean ± SD 348 3.54 ± 1.0 3.82 ± 1.1
Total 353 37(10.5%) 316(89.5%)
women from the less urbanized Ogun State and the metropolitan 
city of Lagos State. This difference was statistically significant. Of 
particular interest is the observation of a dose-response relation-
ship found between HBV positivity and the number of previous 
children reported in the study population. This does-response 
effect was most amplified between pregnant women with no previ-
ous child and those with 1 child (a substantial absolute difference 
of 7.7%). Consequently, 14.4% of pregnant women who had had at 
least 2 children previously had HBV infection and this was statis-
tically significant (Table 4). This implies therefore that the higher 
the number of previous children reported, the higher the likelihood 
of HBV infection in the study population. In contrast, no distinct 
dose-response pattern was found between education and HBV 
infection with highest rate observed in pregnant women that had 
secondary and primary education (12.5% and 12.4% respectively).
7.  A COMPARATIVE ASSESSMENT OF HBV 
KNOWLEDGE AND EXPOSURE
In order to further characterize the predictive pattern of HBV 
infection in the population, this study conducted a comparative 
assessment of HBV positive and negative pregnant women regard-
ing knowledge of HBV infection and its transmission and previous 
testing as presented in Table 5. We found marginally significant evi-
dence in the difference between the HBV positive and negative preg-
nant women with regard to previous HBV test. The result showed 
that higher proportion of HBV negative pregnant women had had 
HBV test prior to the study (a percent point difference of 12.4%. 
On the other hand, we observed a very poor rate of knowledge of 
previous HBV results in both groups as only 1 pregnant woman in 
the entire study population reported knowledge of previous HBV 
result (Table 5). Similarly, higher proportion of HBV negative par-
ticipants (66%) believed that HBV is more easily spread than HIV 
relative to 46% in HBV positive pregnant women (p-value = 0.012). 
Another key aspect of our finding is that blood transfusion in the 
past 3 months was reported 5 times more likely in the HBV positive 
pregnant women relative to their negative counterparts (Table 5). 
This was found to be statistically significant. A comparative high 
proportion of both groups had knowledge that HBV is vaccine-pre-
ventable (>90%) and can be transmitted through blood (>70%). On 
the other hand, a statistically significant difference was found in 
the knowledge of HBV transmission through sex. HBV negative 
pregnant women had higher knowledge of sexual transmission of 
HBV infection.
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8.  INFERENTIAL ANALYSIS OF HIV RISK IN 
THE STUDY POPULATION
We implemented a logistic regression model to obtain age 
adjusted effect of significant risk factors. The result is presented 
in Table 6. The model showed marginal evidence for increased 
odds of HBV infection in pregnant women from Ogun state 
while other factors in the model are held constant. In addition, 
knowledge of HBV being more easily spread than HIV signifi-
cantly reduced odds of HBV infection by 60% (OR: 0.41; 95% 
CI: 0.19–0.88). A similarly protective effect was observed with 
regard to knowledge of HBV transmission through sex with 70% 
reduction in odds of infection (OR: 0.30; 95% CI: 0.11–0.82). On 
the other hand, pregnant women who had blood transfusion in 
the past three months had 9 times significantly greater odds of 
HBV infection.
However, only two pregnant women had co-infection with HIV 
resulting in a low HBV/HIV prevalence burden of 0.57%.
9.  ASSESSMENT OF IMPACT MEASURES 
OF RISK FACTORS OF HBV INFECTION 
ON THE PREGNANT WOMEN  
POPULATION
We further examined the public health impact of exposure risks 
within the various categories of factors investigated to better quan-
tify the increment and preventive impact of public health measures. 
The two key measures considered for the purpose of this study are 
the attributable fraction (also known as attributable proportion) 
simply defined as the proportion of HBV infection in the exposed 
group that can be attributed to the exposure. Similarly, it may also 
be described as the proportion of disease in the group that could be 
prevented by eliminating the risk factor. Giving the cross-sectional 
study design of the current study, we derived odds ratio-based esti-
mates of attributable proportion and preventive fraction in line 
with the relative risks based estimated commonly used in cohort 
based studies. The second category of impact measures considered 
is the population attributable fraction which is briefly defined as 
the proportion of HBV cases in the entire study population that can 
be attributed to the exposure. On this premise, while the first mea-
sure is exposure group specific, the second measure simply scales 
the impact of the effect to the entire population in the study. We 
present the result in Table 7.
Table 6 | Risk factors of HBV in pregnant women
Variable Odds ratio  (95% CI) S.E
P-value 
(<0.05)
Age
 15–24 –
 25–34 2.73(0.54–13.83) 2.26 0.224
 ≥35 1.35(0.18–10.14) 1.39 0.774
 Age at first sex 0.96(0.87–1.05) 0.05 0.359
State of origin
 Lagos –
 Ogun 2.37(0.97–5.81) 1.08 0.059
HBV more easily spread than HIV
 no –
 yes 0.41(0.19–0.88) 0.16 0.022
HBV transmission through sex
 no –
 yes 0.30(0.11–0.82) 0.15 0.019
Blood transfusion in the past 3 months
 no –
 yes 9.50(1.58–57.14) 8.70 0.014
LR Chi2(7), 25.33; Prob > chi2, 0.0007; N, 299; 95% CI, 95% Confidence Interval;  
S.E, Standard error.
Table 7 | Attributable proportion and population attributable fraction of key HBV socio-demographic and exposure variables
Exposure OR (95% CI) AFexp/APexp(95% CI) PFexp (95% CI) PAF/PFpop p-value (exact)
Age group
 15–24 0.49(0.12–2.07) – 0.51(−1.07 to 0.88) 0.05 0.559
 25–34 2.01(0.87–4.68) 0.50(−0.15 to 0.79) – 0.41 0.131
 >=35 0.57(0.22–1.50) – 0.43(−0.50 to 0.78) 0.09 0.292
Education
 primary 1.41(0.71–2.79) 0.29(−0.40 to 0.64) – 0.14 0.378
 secondary 1.26(0.50–3.21) 0.21(−1.01 to 0.69) – 0.03 0.614
 higher 0.74(0.36–1.50) – 0.26(−0.50 to 0.64) 0.11 0.482
Parity
 0 0.19(0.05–0.72) – 0.81(0.28–0.95) 0.18 0.010
 1 0.98(0.49–1.98) – 0.02(−0.98 to 0.51) 0.01 1.000
 2 1.74(0.87–3.48) 0.42(−0.15 to 0.71) – 0.17 0.129
State
 Lagos 0.36(0.16–0.82) – 0.64(0.18–0.84) 0.24 0.020
 Ogun 2.59(1.13–5.93) 0.61(0.11–0.83) – 0.50 0.029
Previous HBV test 0.43(0.17–1.13) – 0.57(−0.13 to 0.83) 0.15 0.108
HBV more easily spread than HIV 0.42(0.22–0.83) – 0.58(0.17–0.78) 0.39 0.017
Blood transfusion in the past 3 months 5.45(1.45–20.52) 0.82(0.31–0.95) – 0.07 0.042
Think HBV can cause liver cancer 1.15(0.57–2.30) 0.13(−0.75 to 0.56) – 0.05 0.722
HBV transmitted through sex 0.32(0.13–0.78) – 0.68(0.22–0.87) 0.63 0.0219
Genital sore 1.90(0.40–8.96) 0.48(−1.47 to 0.89) – 0.03 0.333
p-value less than 5% are in bold.
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We particularly noted the impact of four significant risk factors 
after adjusting for socio-demographic effects. These are parity, 
knowledge of HBV transmission, blood transfusion in the past 
three months and HBV transmission through sex. The attribut-
able proportion of HBV infection among pregnant women with 
at least 2 previous children was 42%. In other words, 42% of all 
cases of HBV infections in this exposure category are actually due 
to the effect of this exposure group. On the other hand, a statisti-
cally significant preventable fraction of 81% was found in pregnant 
women with no history of previous birth (Table 7). With regard to 
knowledge of HBV easier transmission than HIV, we found a sta-
tistically significant preventable fraction of 58% in those who had 
this knowledge compared to those who did not. In contrast, blood 
transfusion in the past 3 months is attributable to 82% of all HBV 
infected pregnant women who had blood transfusion in the past 
3 months. Finally, we found a statistically significant 68% prevent-
able fraction in the odds of HBV infection in pregnant women who 
had knowledge of HBV transmission through sex.
10. DISCUSSION
This study examined the prevalence of the Hepatitis B virus (HBV) 
infection among pregnant women enrolled for antenatal care 
across ten facilities in Lagos and Ogun States, Nigeria. The over-
all HBV prevalence estimate in this study population was 10.5%. 
This estimated burden effectively classifies HBV infection as highly 
endemic (>8%) among pregnant women in south-west Nigeria 
according to the World Health Organization [25]. This provides 
another more recent evidence for the persistence of the Hepatitis B 
virus infection burden and spread in Nigeria. The prevalence esti-
mate was consistent with similar studies conducted in the region 
and other parts of the country. For instance, the recent and most 
nationally representative HBV prevalence burden was reported 
to be 12.2% [26], while the most comprehensive meta-analytical 
study conducted till date (2000–2013) on HBV burden in Nigeria 
found an overall pooled estimate of 13.6% national prevalence and 
a 14.1% burden in pregnant women attending antenatal clinics 
across the country [27]. A similar study conducted in the region at 
the University College Hospital Ibadan, found 8.3% frequency of 
HBV infection in the study population [23].
A comparative estimate was found in studies conducted in the 
northern part of the country. For instance, Ndams et al. (2008) [10] 
found a 12.3% HBV prevalence rate among pregnant women 
in Minna, Nigeria while a case-control study by Yakasai and his 
colleagues (2012) reported an estimate of 7.9% HBV prevalence 
burden in pregnant women of child bearing age at Aminu Kano 
Teaching Hospital Kano, northern Nigeria. Similar estimates were 
found in the north-central part of the country; 11% in Markurdi 
[28] and 7%–8% in Abuja [29,30]. However lower prevalence rates 
have been reported by recent studies in the south-south region of 
Nigeria; viz 2.2% among pregnant women receiving ANC in a tra-
ditional birth home in Benin City [14] and 2.9% in a five-year prev-
alence study in Port Harcourt [15].
In addition, in this study, we found that pregnant women from 
Ogun state (13.2%) are 2.4 times more likely to have HBV infection 
than pregnant women from Lagos State (5.6%). Prevalence estimate 
among pregnant women in Ogun State is higher (13.2%) than the 
6.7% rate reported by Emmanuel and Ifeanyi, 2015 [31] in a similar 
population of pregnant women in Ogun State. On the other hand, 
the observed prevalence rate among pregnant women from Lagos 
State was consistent with estimates by Rabiu et al. (2010) [32] and 
Adegbesan-Omilabu et al. (2015) [33] of 6% and 7.3% respectively. 
The observed lower rate in Lagos State relative to Ogun State may 
be as a result of higher level of education and easy access to health-
care interventions in the metropolitan city of Lagos.
Furthermore, a statistically significant dose-response relationship 
was observed between parity and the likelihood of HBV infection. 
Findings showed a significant increase in the likelihood of HBV 
infection with the increasing number of parity in the study popula-
tion. A similar study conducted by Ngaira et al. (2016) [34] found 
significant association between parity and risk of HBV infection 
in Kenya. This association strongly suggests the institutional fac-
tors within health facilities that may account for the higher number 
of cases observed in previous pregnancies. With each succeeding 
pregnancy, women are likely to visit the healthcare facility for 
antenatal care services, which may require injection of fluids or 
blood into the body in emergency situations or due to complica-
tions. On the other hand, majority of pregnant women previously 
tested HBV positive may have had the HBV DNA replicating in 
their body since their first or second parity, while they never seek 
treatment either due to lack of knowledge of their positive status 
or lack of affordable access to effective treatment. The observed 
higher rate in pregnant women in the middle age group may be due 
to high frequency of sexual activity with their partner which makes 
them more likely to become pregnant and thus seek antenatal care 
services at health facilities [35].
In addition, pregnant women with history of previous HBV test 
and HBV transmission have a likelihood of reduced HBV infec-
tion. This finding is consistent with already known effectiveness of 
knowledge of HBV transmission and its translation to reduced risk 
of infection in this high risk population. Another key finding from 
our study is the significant association between blood transfusion 
and HBV infection as HBV positive pregnant women were 5 times 
more likely to have had blood transfusion in the past 3 months. 
This finding is consistent with similar studies conducted in Nigeria 
[5,11,23,36] and elsewhere [19,34]. One key explanation for this 
observed association is the fact that pregnant women in developing 
countries are prone to obstetric complications due to poor health 
infrastructure, high cost of specialized medical services along with 
sub-optimal clinical practices and lack of essential skills among 
health personnel required to effectively manage their conditions 
[3,26]. As a result, it is not uncommon for emergency situations 
to arise at critical point of care that warrants transfusion of blood. 
However, in most cases of blood transfusion in such a poorly mon-
itored health care setting, blood screening for infections such as 
HBV and other blood-borne pathogens are rarely conducted on 
a routinely basis. This accounts for the often reported association 
between blood transfusion and higher HBV infection in pregnant 
women as reported by previous studies in Nigeria and other devel-
oping countries [15,35–37]. We also found evidence for the con-
tinuing effectiveness of knowledge of HBV sexual transmission as 
a potent risk reduction tool in the study population. Given the high 
knowledge of HBV vaccine in the study population, effort to make 
HBV vaccine accessible and available to this population will pro-
vide significant public health gains in terms of impact measures 
attributable to this exposure and subsequently reduce the transmis-
sion and rate of HBV spread.
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In conclusion, the observed high prevalence of HBV infection in 
this study population provides evidence for the high endemicity of 
HBV infection among pregnant women in south-west Nigeria and 
the need for urgent intervention effective at a population scale. The 
evidence in this study shows that the screening of blood and blood 
products within healthcare facilities remains a topmost public 
health intervention priority if the gains due to high knowledge of 
transmission are to be effectively translated to progressive trends in 
prevention and control.
11. STUDY LIMITATIONS
The cross-sectional study design of the study did not allow for esti-
mate of HBV risk in this high risk population group. Secondly, a 
sample size of 353 is still relatively small for an accurate estimate 
and representative estimate of HBV burden (HBsAg-surface anti-
gen) in pregnant women in south-west Nigeria; hence, we con-
sider this an improved estimate relative to previous studies. More 
so, only ten health facilities were screened which do not give a 
representative sample for the total health facilities present in the 
south-western Nigeria. Finally, we only screened for the hepatitis 
B surface antigen (which provides estimate of existing infection) 
rather than hepatitis e-antigen (which provide better estimate of 
recent HBV transmission in the study population and intensity of 
viral DNA replication).
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